SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-033655
Filing Date
2023-12-05
Accepted
2023-12-05 16:30:25
Documents
13
Period of Report
2023-11-29
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 FORM 8-K arch20231205_8k.htm   iXBRL 8-K 20729
  Complete submission text file 0001437749-23-033655.txt   139636

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA arch-20231129.xsd EX-101.SCH 3409
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arch-20231129_def.xml EX-101.DEF 10353
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE arch-20231129_lab.xml EX-101.LAB 13836
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arch-20231129_pre.xml EX-101.PRE 10348
7 EXTRACTED XBRL INSTANCE DOCUMENT arch20231205_8k_htm.xml XML 2322
Mailing Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702
Business Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 617-431-2313
Arch Therapeutics, Inc. (Filer) CIK: 0001537561 (see all company filings)

IRS No.: 460524102 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-54986 | Film No.: 231467018
SIC: 3841 Surgical & Medical Instruments & Apparatus